- Home
- SPB vs KARD Comparison
SPB vs KARD Comparison
Compare SPB & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPB | KARD |
|---|---|---|
| Founded | 1906 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.2B |
| IPO Year | 1994 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SPB | KARD |
|---|---|---|
| Price | $79.92 | $12.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $98.75 | $38.67 |
| AVG Volume (30 Days) | 291.2K | ★ 600.4K |
| Earning Date | 11-12-2026 | 11-22-2026 |
| Dividend Yield | ★ 2.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $3,802,100,000.00 | N/A |
| Revenue This Year | $1.92 | N/A |
| Revenue Next Year | $1.26 | $50.00 |
| P/E Ratio | $80.07 | ★ N/A |
| Revenue Growth | ★ 20.86 | N/A |
| 52 Week Low | $51.41 | $12.23 |
| 52 Week High | $99.06 | $27.00 |
Technical Indicators
Market Signals| Indicator | SPB | KARD |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 35.50 |
| Support Level | $77.74 | $12.23 |
| Resistance Level | $80.83 | $15.93 |
| Average True Range (ATR) | 1.77 | 1.32 |
| MACD | 0.61 | 0.08 |
| Stochastic Oscillator | 81.51 | 13.24 |
Price Performance
Historical ComparisonAbout SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.
About KARD Kardigan Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.